12-53501450-C-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_134323.2(TARBP2):āc.42C>Gā(p.Cys14Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000765 in 1,568,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_134323.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TARBP2 | NM_134323.2 | c.42C>G | p.Cys14Trp | missense_variant | 1/9 | ENST00000266987.7 | NP_599150.1 | |
TARBP2 | XM_047429485.1 | c.42C>G | p.Cys14Trp | missense_variant | 1/7 | XP_047285441.1 | ||
MAP3K12 | XM_011538725.4 | c.-1460G>C | 5_prime_UTR_variant | 1/14 | XP_011537027.1 | |||
TARBP2 | NM_004178.5 | c.-6+449C>G | intron_variant | NP_004169.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152198Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000565 AC: 8AN: 1416776Hom.: 0 Cov.: 31 AF XY: 0.00000428 AC XY: 3AN XY: 700440
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2024 | The c.42C>G (p.C14W) alteration is located in exon 1 (coding exon 1) of the TARBP2 gene. This alteration results from a C to G substitution at nucleotide position 42, causing the cysteine (C) at amino acid position 14 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at